en

PRODUCT DETAIL

EVUSHELD 150 mg + 150 mg injekčný roztok

Code 9995D
MA number EU/1/22/1651/001
Product Form: sol inj 1x1,5 ml/150 mg + 1x1,5 ml/150 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J06 IMMUNE SERA AND IMMUNOGLOBULINS
J06B IMMUNOGLOBULINS
J06BD Antiviral monoclonal antibodies
J06BD03 Tixagevimab and Cilgavimab
Shelf life: 18
Container: glass vial
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 25.03.2022
Validity: 25.03.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.03.2022
eu-flag.png sk-flag.png